Answer
Women of childbearing potential should use effective contraception during pirtobrutinib (Jaypirca) treatment and for 5 weeks after the last dose; men should use effective contraception and not father a child during treatment and for 3 months after the last dose.
Sources for this answer
- Jaypirca 50mg, 100mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked